Glaucoma: Overview
Open Angle Glaucoma: Treatment
Genetic Lingo
Angle Closure Glaucoma: Treatment
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 23, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
O N Levanova1, V A Sokolov1, N A Nikiforov1
1Ryazan State Medical University named after acad. I.P. Pavlov, Ministry of Health of Russia, 9 Vysokovol'tnaya St., Ryazan, Russian Federation, 390026.
Most primary open-angle glaucoma (POAG) patients are heterozygotes for the CFH T402H polymorphism. This genetic factor shifts towards homozygosity as the disease progresses and ganglion cells are lost.
Area of Science:
Context:
Purpose:
Summary:
Impact: